Frazer Morgan
Company: Kinaset Therapeutics, Inc
Job title: Chief Development Officer & Co-Founder
Seminars:
Closing Q&A Panel 5:40 pm
day: Day One
Updates on Non-Oral JAKi Therapy: Unique Challenges & Interest 9:00 am
Outlining current challenges and opportunities with alternative JAKi application Sharing insights from multidisciplinary backgrounds and application experience Speculating on the upcoming therapeutic landscape and potential for alternative JAKi interventionRead more
day: Day Two
Developing inhaled JAKs to Address Unmet Needs in Respiratory Disease 5:15 pm
Detailing the mechanism of action for JAK inhibition in asthma Providing key challenges in inhaled JAK development Describing a KN-002 program overviewRead more
day: Day One